Skip to content

Glycemic control of in patient type2 diabetes mellitus comparing between Thammasart insulin protocol and routine care: randomized-controlled trial

Glycemic control of in patient type2 diabetes mellitus comparing between Thammasart insulin protocol and routine care: randomized-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180316006
Enrollment
90
Registered
2018-03-16
Start date
2018-04-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inhospital hyperglycemia Inhospital hyperglycemia Insulin Diabetes millitus

Interventions

Thammasart insulin protocol,Conventional hyperglycemia treatment according to physician treatment
Experimental Procedure/Surgery,Experimental Procedure/Surgery
Thammasart insulin protocol,Conventional

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old 2.Type2 diabetes millitus 3.Inhospital hyperglycemia 4.Capillary blood glucose 180-300 mg/dL at least 2 times in 24 hrs 5.Admit at Medical ward

Exclusion criteria

Exclusion criteria: 1.Good control capillary blood glucose by diet control 2.Use insulin analog :glargine,determine,aspart,lispro 3.Shock 4.DKA or HHS 5.Plan to move to ICU within 2 days 6.Plan to surgery within 2 days 7.Pregnancy 8.ESRD who must hemodialysis or peritoneal dialysis 9.Use intravenous insulin 10.Capillary blood glucose interferance 11.History of hypertriglyceride (>1800 mg/dL

Design outcomes

Primary

MeasureTime frame
Glycemic control 14 days Capillary blood glucose

Secondary

MeasureTime frame
Hypoglycemia and hyperglycemia events 14 days Incidence report

Countries

Thailand

Contacts

Public ContactThipaporn Tharavanij

Faculty of medicine

thipaporn_t@yahoo.com669269793

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026